Baker Ellis Asset Management LLC Merck & Co., Inc. Transaction History

Baker Ellis Asset Management LLC

$695 Million
Q3 2024

A detailed history of Baker Ellis Asset Management LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Baker Ellis Asset Management LLC holds 12,088 shares of MRK stock, worth $1.23 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

12,088

Previous 11,405 5.99%

Holding current value

$1.23 Million

Previous $1.41 Million 2.76%

% of portfolio

0.2%

Previous 0.21%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$111.15 - $128.97 $75,915 - $88,086	683 Added 5.99%	12,088 $1.37 Million
Q2 2024 Jul 09, 2024	BUY	$123.8 - $132.96 $49,520 - $53,184	400 Added 3.63%	11,405 $1.41 Million
Q1 2024 Apr 17, 2024	BUY	$113.24 - $131.95 $129,093 - $150,423	1,140 Added 11.56%	11,005 $1.45 Million
Q4 2023 Jan 23, 2024	SELL	$100.18 - $109.02 $50,090 - $54,510	-500 Reduced 4.82%	9,865 $1.08 Million
Q3 2023 Oct 24, 2023	SELL	$102.95 - $114.33 $30,885 - $34,299	-300 Reduced 2.81%	10,365 $1.07 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $35,079 - $39,408	415 Added 4.05%	10,665 $918,000
Q4 2021 Jan 27, 2022	SELL	$72.28 - $90.54 $43,368 - $54,324	-600 Reduced 5.53%	10,250 $786,000
Q1 2021 Apr 28, 2021	BUY	$68.86 - $81.11 $6,886 - $8,111	100 Added 0.93%	10,850 $836,000
Q4 2020 Feb 04, 2021	BUY	$71.77 - $79.65 $5,741 - $6,372	80 Added 0.75%	10,750 $879,000
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $14,636 - $16,590	200 Added 1.91%	10,670 $885,000
Q1 2020 May 12, 2020	BUY	$63.36 - $87.82 $257,875 - $357,427	4,070 Added 63.59%	10,470 $806,000
Q4 2019 Feb 10, 2020	SELL	$77.58 - $87.54 $1.09 Million - $1.23 Million	-14,020 Reduced 68.66%	6,400 $582,000
Q1 2019 May 09, 2019	SELL	$69.58 - $79.36 $133,384 - $152,133	-1,917 Reduced 8.58%	20,420 $1.7 Million
Q4 2018 Feb 07, 2019	SELL	$65.24 - $75.71 $19,572 - $22,712	-300 Reduced 1.33%	22,337 $1.71 Million
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $325,256 - $382,481	-5,638 Reduced 19.94%	22,637 $1.61 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $20,027 - $23,529	-394 Reduced 1.37%	28,275 $1.72 Million
Q4 2017 Jan 30, 2018	SELL	$51.62 - $61.64 $42,741 - $51,037	-828 Reduced 2.81%	28,669 $1.61 Million
Q3 2017 Oct 18, 2017	BUY	$58.67 - $63.13 $1.73 Million - $1.86 Million	29,497	29,497 $1.89 Million

Others Institutions Holding MRK

# of Institutions

3,808

Shares Held

1.92B

Call Options Held

13.4M

Put Options Held

10.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $258B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Ellis Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baker Ellis Asset Management LLC with notifications on news.

Account

Baker Ellis Asset Management LLC Merck & Co., Inc. Transaction History